FDA.reportPublic FDA data

benzethonium chloride 2 MG/ML / benzocaine 200 MG/ML Topical Cream [Lanacane]

RxCUI
1300295
RxNorm name
benzethonium chloride 2 MG/ML / benzocaine 200 MG/ML Topical Cream [Lanacane]
Display name
LANACANE (Topical)
Full name
benzethonium chloride 2 MG/ML / benzocaine 200 MG/ML Topical Cream [Lanacane]
Term type
SBD
Status
Active
Strength
0.2-20%
Dose form
Cream
Route
Topical
Updated
2026-06-06 07:17:23

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
072012
Active start
072012
Multiple ingredient
YES
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
benzethonium chloride2 MG / 1 MLbenzethoniumbenzethonium chloride
benzocaine200 MG / 1 MLbenzocainebenzocaine

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Topical Cream316982

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
benzethonium1390
benzocaine1399

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
PRESCRIBABLEYATTRIBUTES
RXNAV_STRLanacane Maximum Strength (benzethonium chloride 0.2 % / benzocaine 20 % ) Topical CreamNAMES
RxNorm Namebenzethonium chloride 2 MG/ML / benzocaine 200 MG/ML Topical Cream [Lanacane]NAMES
RxNorm SynonymLanacane Maximum Strength (benzethonium chloride 0.2 % / benzocaine 20 % ) Topical CreamNAMES
TTYSBDATTRIBUTES
RxCUI1300295CODES
MMSL_CODEBD36798CODES

RxNav Current And Historical NDCs#

NDC11, Source, Active table
NDC11SourceActive
63824081001rxnav_ndcsyes
11509030601rxnav_historical_indirect
11509038101rxnav_historical_indirect

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCD04ABAnesthetics for topical useATC1-4benzocaine
ATCR02ADAnesthetics, localATC1-4benzocaine
ATCR02AAAntisepticsATC1-4benzethonium
ATCN01BAEsters of aminobenzoic acidATC1-4benzocaine
ATCC05ADLocal anestheticsATC1-4benzocaine
ATCD08AJQuaternary ammonium compoundsATC1-4benzethonium chloride
FDASPLN0000185508Standardized Chemical AllergenEPChas_epcbenzocaine
FDASPLN0000184306Cell-mediated ImmunityPEhas_pebenzocaine
FDASPLN0000175629Increased Histamine ReleasePEhas_pebenzocaine
MEDRTD001558BenzethoniumCHEMhas_ingredientbenzethonium
MEDRTD001558BenzethoniumCHEMhas_ingredientbenzethonium chloride
MEDRTD001566BenzocaineCHEMhas_ingredientbenzocaine
MEDRTD001424Bacterial InfectionsDISEASEci_withbenzocaine
MEDRTD002056BurnsDISEASEmay_treatbenzocaine
MEDRTD004342Drug HypersensitivityDISEASEci_withbenzocaine
MEDRTD004433EaracheDISEASEmay_treatbenzocaine
MEDRTD005401Fissure in AnoDISEASEmay_treatbenzocaine
MEDRTD006484HemorrhoidsDISEASEmay_treatbenzocaine
MEDRTD006561Herpes SimplexDISEASEmay_treatbenzocaine
MEDRTD019226Oral UlcerDISEASEmay_treatbenzocaine
MEDRTD010032Otitis ExternaDISEASEmay_treatbenzocaine
MEDRTD010033Otitis MediaDISEASEmay_treatbenzocaine
MEDRTD010146PainDISEASEmay_preventbenzocaine
MEDRTD011537PruritusDISEASEmay_treatbenzocaine
MEDRTD014098ToothacheDISEASEmay_treatbenzocaine
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moabenzocaine
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pebenzocaine

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH2 MG/ML / 200 MG/ML
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
ATTRIBUTESTTYSBD
CODESMMSL_CODEBD36798
CODESRxCUI1300295
NAMESPrescribable SynonymLanacane Maximum Strength 20 % / 0.2 % Topical Cream
NAMESRXNAV_STRLanacane Maximum Strength (benzethonium chloride 0.2 % / benzocaine 20 % ) Topical Cream
NAMESRxNorm Namebenzethonium chloride 2 MG/ML / benzocaine 200 MG/ML Topical Cream [Lanacane]
NAMESRxNorm SynonymLanacane Maximum Strength (benzethonium chloride 0.2 % / benzocaine 20 % ) Topical Cream
SOURCESSourceMultum MediSource Lexicon